These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 26308228)

  • 21. Cost and consequences of noncompliance with osteoporosis treatment among women initiating therapy.
    Modi A; Siris ES; Tang J; Sen S
    Curr Med Res Opin; 2015 Apr; 31(4):757-65. PubMed ID: 25661017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and predictors of osteoporosis medication discontinuation and switching among Medicare beneficiaries.
    Yun H; Curtis JR; Guo L; Kilgore M; Muntner P; Saag K; Matthews R; Morrisey M; Wright NC; Becker DJ; Delzell E
    BMC Musculoskelet Disord; 2014 Apr; 15():112. PubMed ID: 24684864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs of gastrointestinal events after outpatient opioid treatment for non-cancer pain.
    Kwong WJ; Diels J; Kavanagh S
    Ann Pharmacother; 2010 Apr; 44(4):630-40. PubMed ID: 20197473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of severe upper gastrointestinal complications among oral bisphosphonate users.
    Ghirardi A; Scotti L; Zambon A; Della Vedova G; Cavalieri D'oro L; Lapi F; Cipriani F; Caputi AP; Vaccheri A; Gregori D; Gesuita R; Vestri A; Staniscia T; Mazzaglia G; Corrao G;
    PLoS One; 2013; 8(12):e73159. PubMed ID: 24348985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Examining the Effect of Medication Adherence on Risk of Subsequent Fracture Among Women with a Fragility Fracture in the U.S. Medicare Population.
    Keshishian A; Boytsov N; Burge R; Krohn K; Lombard L; Zhang X; Xie L; Baser O
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1178-1190. PubMed ID: 29083977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data.
    Choong CK; Ford JH; Nyhuis AW; Robinson RL; Aurora SK
    J Manag Care Spec Pharm; 2018 Sep; 24(9):921-928. PubMed ID: 30156448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical efficacy and treatment persistence of monthly minodronate for osteoporotic patients unsatisfied with, and shifted from, daily or weekly bisphosphonates: the BP-MUSASHI study.
    Sakai A; Ikeda S; Okimoto N; Matsumoto H; Teshima K; Okazaki Y; Fukuda F; Arita S; Tsurukami H; Nagashima M; Yoshioka T
    Osteoporos Int; 2014 Sep; 25(9):2245-53. PubMed ID: 24899103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.
    Thorsteinsson AL; Vestergaard P; Eiken P
    Osteoporos Int; 2014 Jul; 25(7):1937-44. PubMed ID: 24664275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral bisphosphonates do not increase the risk of severe upper gastrointestinal complications: a nested case-control study.
    Ghirardi A; Scotti L; Vedova GD; D'Oro LC; Lapi F; Cipriani F; Caputi AP; Vaccheri A; Gregori D; Gesuita R; Vestri A; Staniscia T; Mazzaglia G; Corrao G;
    BMC Gastroenterol; 2014 Jan; 14():5. PubMed ID: 24397769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upper gastrointestinal tolerability of alendronate sodium monohydrate 10 mg once daily in postmenopausal women: a 12-week, randomized, double-blind, placebo-controlled, exploratory study.
    Adachi JD; Faraawi RY; O'Mahony MF; Nayar A; Massaad R; Evans JK; Yacik C
    Clin Ther; 2009 Aug; 31(8):1747-53. PubMed ID: 19808133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral bisphosphonates and upper gastrointestinal tract problems: what is the evidence?
    Cryer B; Bauer DC
    Mayo Clin Proc; 2002 Oct; 77(10):1031-43. PubMed ID: 12374247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of gastrointestinal events with quality of life and treatment satisfaction in osteoporosis patients: results from the Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC OS).
    Modi A; Sen S; Adachi JD; Adami S; Cortet B; Cooper AL; Geusens P; Mellström D; Weaver JP; van den Bergh JP; Keown PA; Sajjan S
    Osteoporos Int; 2017 Oct; 28(10):2867-2876. PubMed ID: 28643048
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between refill compliance to oral bisphosphonate treatment, incident fractures, and health care costs--an analysis using national health databases.
    Olsen KR; Hansen C; Abrahamsen B
    Osteoporos Int; 2013 Oct; 24(10):2639-47. PubMed ID: 23604250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral bisphosphonates and upper gastrointestinal toxicity: a study of cancer and early signals of esophageal injury.
    Morden NE; Munson JC; Smith J; Mackenzie TA; Liu SK; Tosteson AN
    Osteoporos Int; 2015 Feb; 26(2):663-72. PubMed ID: 25349053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adverse events and intravenous versus oral bisphosphonate use in patients with osteoporosis and cancer in the U.S.
    Skrepnek GH; Seal B; Tangirala M; Jeffcoat MK; Watts NB; Hay JW
    Gen Dent; 2010; 58(6):484-92; quiz 493-4. PubMed ID: 21062718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Healthcare resource utilization and costs 2 years pre- and post-lumbar spine surgery for stenosis: a national claims cohort study of 22,182 cases.
    Koltsov JCB; Sambare TD; Alamin TF; Wood KB; Cheng I; Hu SS
    Spine J; 2022 Jun; 22(6):965-974. PubMed ID: 35123048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burden of illness among patients with dementia-related psychosis.
    Frazer M; Abler V; Halpern R; Skoog B; Rashid N
    J Manag Care Spec Pharm; 2021 Mar; 27(3):367-378. PubMed ID: 33645238
    [No Abstract]   [Full Text] [Related]  

  • 38. Association of gastrointestinal events with osteoporosis treatment initiation and treatment compliance in Germany: An observational study.
    Modi A; Fan CS; Tang J; Weaver JP; Sajjan S
    Bone Rep; 2016 Dec; 5():208-213. PubMed ID: 28580388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Burden of illness and costs associated with eosinophilic granulomatosis with polyangiitis: evidence from a managed care database in the United States.
    Bell CF; Blauer-Peterson C; Mao J
    J Manag Care Spec Pharm; 2021 Sep; 27(9):1249-1259. PubMed ID: 34165321
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of teriparatide adherence and persistence with clinical and economic outcomes in Medicare Part D recipients: a retrospective cohort study.
    Hazel-Fernandez L; Louder AM; Foster SA; Uribe CL; Burge RT
    BMC Musculoskelet Disord; 2013 Jan; 14():4. PubMed ID: 23281846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.